Craft

Cell MedX

Stock Price

$0

2024-10-29

Market Capitalization

$8.5 M

2024-10-29

Revenue

$95.8 K

FY, 2020

Cell MedX Summary

Company Summary

Overview
Cell MedX Corp. is a development-stage biotech company. The Company is focused on the commercialization and development of microcurrent therapeutic devices that promote general wellness and alleviate complications associated with medical conditions including, but not limited to, diabetes, Parkinson's disease, & high blood pressure.
Type
Public
Status
Active
Founded
2014
HQ
Carson City, NV, US | view all locations
Website
http://cellmedx.com/
Cybersecurity rating
Sectors

Key People

  • Bradley Hargreaves, Vice President of Technology and Operations and Director

    • George Adams, Director

      • Frank McEnulty, Director

        • Yanika Silina, Chief Financial Officer, Treasurer, Secretary, and Director

          LocationsView all

          1 location detected

          • Carson City, NV HQ

            United States

            123 W Nye Ln #446

          Cell MedX Financials

          Summary Financials

          Net income (Q3, 2026)
          ($90.6K)
          Cash (Q3, 2026)
          $10.3K

          Footer menu